JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Correction for Laudon et al., J Endocrinol 116 (1) 43-53.
Journal of Endocrinology (1988) 118, 168-       DOI: 10.1677/joe.0.1180168
© 1988 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Correction

 In the paper by Laudon et al. published in J. Endocr. (1988) 116, 43–53 the nomenclature of the melatonin antagonist should be N-(2,4-dinitrophenyl)-5-methoxytryptamine instead of N-(3,5-dinitrophenyl)-5-methoxytryptamine, and the starting material should be fluoro-2,4-dinitrobenzene instead of fluoro-3,5-dinitrobenzene.






HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the Society for Endocrinology.